BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 16467676)

  • 1. Intravitreal toxicity of moxifloxacin.
    Aydin E; Kazi AA; Peyman GA; Esfahani MR
    Retina; 2006 Feb; 26(2):187-90. PubMed ID: 16467676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravitreal toxicity of garenoxacin.
    Esfahani MR; Kazi AA; Peyman GA; Dellacroce JT; Aydin E
    Retina; 2006 Feb; 26(2):182-6. PubMed ID: 16467675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Retinal toxicity of intravitreal doxycycline. A pilot study].
    Aydin E; Kazi AA; Peyman GA; Esfahani MR; Muñoz-Morales A; Kivilcim M; Caro-Magdaleno M
    Arch Soc Esp Oftalmol; 2007 Apr; 82(4):223-8. PubMed ID: 17443427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravitreal toxicity of levofloxacin and gatifloxacin.
    Kazi AA; Jermak CM; Peyman GA; Aydin E; Riazi-Esfahani M
    Ophthalmic Surg Lasers Imaging; 2006; 37(3):224-9. PubMed ID: 16749259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravitreal moxifloxacin: retinal safety study with electroretinography and histopathology in animal models.
    Gao H; Pennesi ME; Qiao X; Iyer MN; Wu SM; Holz ER; Mieler WF
    Invest Ophthalmol Vis Sci; 2006 Apr; 47(4):1606-11. PubMed ID: 16565399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ocular toxicity of intravitreal tacrolimus.
    Passos E; Genaidy MM; Peyman GA
    Ophthalmic Surg Lasers; 2002; 33(2):140-4. PubMed ID: 11942546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intracameral Vigamox (moxifloxacin 0.5%) is non-toxic and effective in preventing endophthalmitis in a rabbit model.
    Kowalski RP; Romanowski EG; Mah FS; Yates KA; Gordon YJ
    Am J Ophthalmol; 2005 Sep; 140(3):497-504. PubMed ID: 16083841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experimental intravitreal application of trovafloxacin in rabbits.
    Gürler B; Ozkul Y; Bitiren M; Satici A; Oguz H; Karadede S
    Ophthalmic Res; 2001; 33(4):228-36. PubMed ID: 11464076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravitreal toxicity of ketorolac tris salt and flurbiprofen.
    Morales AM; Kivilcim M; Peyman GA; Main M; Manzano RP
    Ophthalmic Surg Lasers Imaging; 2009; 40(1):38-42. PubMed ID: 19205494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravitreal toxicity of high-dose etanercept.
    Kivilcim M; Peyman GA; Kazi AA; Dellacroce J; Ghobrial RN; Monzano R
    J Ocul Pharmacol Ther; 2007 Feb; 23(1):57-62. PubMed ID: 17341152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of intravitreally injected povidone-iodine on Staphylococcus epidermidis in rabbit eyes.
    Trost LW; Kivilcim M; Peyman GA; Aydin E; Kazi AA
    J Ocul Pharmacol Ther; 2007 Feb; 23(1):70-7. PubMed ID: 17341154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ocular toxicity of intravitreal clarithromycin.
    Unal M; Peyman GA; Liang C; Hegazy H; Molinari LC; Chen J; Brun S; Tarcha PJ
    Retina; 1999; 19(5):442-6. PubMed ID: 10546942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retinal toxicity of commercial intravitreal tissue plasminogen activator solution in cat eyes.
    Hrach CJ; Johnson MW; Hassan AS; Lei B; Sieving PA; Elner VM
    Arch Ophthalmol; 2000 May; 118(5):659-63. PubMed ID: 10815158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety of moxifloxacin as shown in animal and in vitro studies.
    McGee DH; Holt WF; Kastner PR; Rice RL
    Surv Ophthalmol; 2005 Nov; 50 Suppl 1():S46-54. PubMed ID: 16257310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of intravitreal moxifloxacin and dexamethasone in experimental Staphylococcus aureus endophthalmitis.
    Ermis SS; Cetinkaya Z; Kiyici H; Inan UU; Ozturk F
    Curr Eye Res; 2007 Apr; 32(4):337-44. PubMed ID: 17453955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ocular toxicity of intravitreal trovafloxacin in the pigmented rabbit.
    Ng EW; Joo MJ; Au Eong KG; Green WR; O'Brien TP
    Curr Eye Res; 2003 Dec; 27(6):387-93. PubMed ID: 14704922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of vitreous clearance and potential retinal toxicity of intravitreal lornoxicam (xefo).
    Diakonis VF; Tsourdou A; Tzatzarakis MN; Tsika C; Charisis S; Naoumidi I; Plainis S; Tsilimbaris MK
    J Ocul Pharmacol Ther; 2013 Sep; 29(7):627-32. PubMed ID: 23556534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ocular pharmacokinetics, safety and efficacy of intracameral moxifloxacin 0.5% solution in a rabbit model.
    Asena L; Akova YA; Goktaş MT; Bozkurt A; Yaşar U; Karabay G; Demiralay E
    Curr Eye Res; 2013 Apr; 38(4):472-9. PubMed ID: 23373761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Testing intravitreal toxicity of bevacizumab (Avastin).
    Manzano RP; Peyman GA; Khan P; Kivilcim M
    Retina; 2006 Mar; 26(3):257-61. PubMed ID: 16508423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retinal function and histologic changes following intravitreal injection of indocyanine green in a rabbit model.
    Chao AN; Chen SN; Kuo YH
    J Ocul Pharmacol Ther; 2004 Oct; 20(5):450-9. PubMed ID: 15650520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.